CN109071523A - 一种脲类化合物、其制备方法及其医药用途 - Google Patents
一种脲类化合物、其制备方法及其医药用途 Download PDFInfo
- Publication number
- CN109071523A CN109071523A CN201780026742.3A CN201780026742A CN109071523A CN 109071523 A CN109071523 A CN 109071523A CN 201780026742 A CN201780026742 A CN 201780026742A CN 109071523 A CN109071523 A CN 109071523A
- Authority
- CN
- China
- Prior art keywords
- phenyl
- tert
- butyl
- urea
- benzoimidazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
提供一种通式(I)所示的脲类化合物、其药学上可接受的盐,及其制备方法,以及其作为FLT3酪氨酸蛋白激酶抑制剂,特别是在预防和/或治疗癌症中的用途。
Description
PCT国内申请,说明书已公开。
Claims (23)
- PCT国内申请,权利要求书已公开。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610142049X | 2016-03-11 | ||
CN201610142049.XA CN107176951A (zh) | 2016-03-11 | 2016-03-11 | 一种脲类化合物、其制备方法及其医药用途 |
PCT/CN2017/076265 WO2017152874A1 (zh) | 2016-03-11 | 2017-03-10 | 一种脲类化合物、其制备方法及其医药用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109071523A true CN109071523A (zh) | 2018-12-21 |
CN109071523B CN109071523B (zh) | 2022-05-31 |
Family
ID=59790078
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610142049.XA Pending CN107176951A (zh) | 2016-03-11 | 2016-03-11 | 一种脲类化合物、其制备方法及其医药用途 |
CN201780026742.3A Active CN109071523B (zh) | 2016-03-11 | 2017-03-10 | 一种脲类化合物、其制备方法及其医药用途 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610142049.XA Pending CN107176951A (zh) | 2016-03-11 | 2016-03-11 | 一种脲类化合物、其制备方法及其医药用途 |
Country Status (10)
Country | Link |
---|---|
US (1) | US10647680B2 (zh) |
EP (1) | EP3424924B1 (zh) |
JP (1) | JP6927994B2 (zh) |
KR (1) | KR102430942B1 (zh) |
CN (2) | CN107176951A (zh) |
AU (1) | AU2017230437B2 (zh) |
DK (1) | DK3424924T3 (zh) |
HK (1) | HK1258545A1 (zh) |
RU (1) | RU2741596C2 (zh) |
WO (1) | WO2017152874A1 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017152126A1 (en) | 2016-03-03 | 2017-09-08 | Cornell University | Small molecule ire1-alpha inhibitors |
CN107176951A (zh) | 2016-03-11 | 2017-09-19 | 恩瑞生物医药科技(上海)有限公司 | 一种脲类化合物、其制备方法及其医药用途 |
WO2018161033A1 (en) * | 2017-03-02 | 2018-09-07 | Wright, Adrian | Small molecule ire1-alpha inhibitors |
CN110016014B (zh) * | 2018-01-08 | 2023-02-17 | 中国科学院上海药物研究所 | Ezh2抑制剂及其制备和抗肿瘤治疗中的应用 |
EP3906029A4 (en) | 2018-12-31 | 2022-09-21 | Biomea Fusion, LLC | INHIBITORS OF MENIN-MLL INTERACTION |
EP3906026A4 (en) | 2018-12-31 | 2022-10-19 | Biomea Fusion, LLC | IRREVERSIBLE MENIN-MLL INTERACTION INHIBITORS |
CN112552302B (zh) * | 2019-09-26 | 2022-05-13 | 深圳市塔吉瑞生物医药有限公司 | 取代的芳香稠合环衍生物及其组合物及用途 |
WO2021104461A1 (zh) * | 2019-11-29 | 2021-06-03 | 南京明德新药研发有限公司 | 二氮杂吲哚类衍生物及其作为Chk1抑制剂的应用 |
CN114341128B (zh) * | 2020-07-24 | 2024-06-25 | 恩瑞生物医药科技(上海)有限公司 | 双功能蛋白降解靶向嵌合体类化合物及其制备方法和医药用途 |
AU2022331496A1 (en) | 2021-08-20 | 2024-02-29 | Biomea Fusion, Inc. | Crystalline form of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo -2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide, an irreversible menin-mll inhibitor for the treatment of cancer |
CN113861179A (zh) * | 2021-10-22 | 2021-12-31 | 上海应用技术大学 | 一种新型flt3激酶抑制剂及其合成与应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1724258A1 (en) * | 2004-02-23 | 2006-11-22 | Chugai Seiyaku Kabushiki Kaisha | Heteroarylphenylurea derivative |
WO2007112093A2 (en) * | 2006-03-23 | 2007-10-04 | Synta Pharmaceuticals Corp. | Benzimidazolyl-pyridine compounds for inflammation and immune-related uses |
CN101239978A (zh) * | 2008-03-05 | 2008-08-13 | 南方医科大学 | 一种咪唑并吡啶类化合物 |
CN102153551A (zh) * | 2010-04-02 | 2011-08-17 | 济南海乐医药技术开发有限公司 | 基于吲唑或氮杂吲唑的双芳基脲或硫脲类结构抗肿瘤药物 |
CN102319242A (zh) * | 2011-10-13 | 2012-01-18 | 济南海乐医药技术开发有限公司 | 吲唑双芳基脲化合物作为蛋白激酶抑制剂的应用 |
CN103450152A (zh) * | 2012-06-04 | 2013-12-18 | 济南海乐医药技术开发有限公司 | 基于吲唑、吲哚或氮杂吲唑、氮杂吲哚的双芳基脲类结构抗肿瘤药物 |
CN104513252A (zh) * | 2013-09-26 | 2015-04-15 | 广东东阳光药业有限公司 | 取代脲衍生物及其在药物中的应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1567393A (en) * | 1925-03-16 | 1925-12-29 | Schlaich Herman | Radiator cap |
DE3783070T2 (de) * | 1986-03-18 | 1993-05-13 | Sandoz Ag | Phenylharnstoffe. |
GB9823873D0 (en) * | 1998-10-30 | 1998-12-30 | Pharmacia & Upjohn Spa | 2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents |
WO2005042495A1 (en) * | 2003-10-21 | 2005-05-12 | Imclone Systems Incorporated | (benzimidazol-2-yl)-phenyl-phenyl-urea compounds and methods for inhibiting heparanase activity |
US20140243324A1 (en) * | 2010-11-18 | 2014-08-28 | Ligand Pharmaceuticals Incorporated | Use of hematopoietic growth factor mimetics |
CN103864792B (zh) * | 2012-12-12 | 2017-01-18 | 山东亨利医药科技有限责任公司 | 作为酪氨酸激酶抑制剂的含氮并环类化合物 |
CN107176951A (zh) | 2016-03-11 | 2017-09-19 | 恩瑞生物医药科技(上海)有限公司 | 一种脲类化合物、其制备方法及其医药用途 |
-
2016
- 2016-03-11 CN CN201610142049.XA patent/CN107176951A/zh active Pending
-
2017
- 2017-03-10 CN CN201780026742.3A patent/CN109071523B/zh active Active
- 2017-03-10 DK DK17762560.5T patent/DK3424924T3/da active
- 2017-03-10 RU RU2018131539A patent/RU2741596C2/ru active
- 2017-03-10 AU AU2017230437A patent/AU2017230437B2/en active Active
- 2017-03-10 JP JP2018547295A patent/JP6927994B2/ja active Active
- 2017-03-10 WO PCT/CN2017/076265 patent/WO2017152874A1/zh active Application Filing
- 2017-03-10 KR KR1020187028521A patent/KR102430942B1/ko active IP Right Grant
- 2017-03-10 EP EP17762560.5A patent/EP3424924B1/en active Active
- 2017-03-10 US US16/078,054 patent/US10647680B2/en active Active
-
2019
- 2019-01-18 HK HK19100900.8A patent/HK1258545A1/zh unknown
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1724258A1 (en) * | 2004-02-23 | 2006-11-22 | Chugai Seiyaku Kabushiki Kaisha | Heteroarylphenylurea derivative |
WO2007112093A2 (en) * | 2006-03-23 | 2007-10-04 | Synta Pharmaceuticals Corp. | Benzimidazolyl-pyridine compounds for inflammation and immune-related uses |
CN101239978A (zh) * | 2008-03-05 | 2008-08-13 | 南方医科大学 | 一种咪唑并吡啶类化合物 |
CN102153551A (zh) * | 2010-04-02 | 2011-08-17 | 济南海乐医药技术开发有限公司 | 基于吲唑或氮杂吲唑的双芳基脲或硫脲类结构抗肿瘤药物 |
CN102319242A (zh) * | 2011-10-13 | 2012-01-18 | 济南海乐医药技术开发有限公司 | 吲唑双芳基脲化合物作为蛋白激酶抑制剂的应用 |
CN103450152A (zh) * | 2012-06-04 | 2013-12-18 | 济南海乐医药技术开发有限公司 | 基于吲唑、吲哚或氮杂吲唑、氮杂吲哚的双芳基脲类结构抗肿瘤药物 |
CN104513252A (zh) * | 2013-09-26 | 2015-04-15 | 广东东阳光药业有限公司 | 取代脲衍生物及其在药物中的应用 |
Non-Patent Citations (1)
Title |
---|
来源于CHEMICAL LIBRARY: ""STN检索报告"", 《数据库REGISTRY(在线)》 * |
Also Published As
Publication number | Publication date |
---|---|
US10647680B2 (en) | 2020-05-12 |
JP6927994B2 (ja) | 2021-09-01 |
JP2019507779A (ja) | 2019-03-22 |
AU2017230437A1 (en) | 2018-09-06 |
WO2017152874A1 (zh) | 2017-09-14 |
CN107176951A (zh) | 2017-09-19 |
RU2018131539A (ru) | 2020-04-13 |
RU2018131539A3 (zh) | 2020-04-13 |
EP3424924B1 (en) | 2023-05-24 |
CN109071523B (zh) | 2022-05-31 |
AU2017230437B2 (en) | 2020-11-26 |
KR20180132664A (ko) | 2018-12-12 |
KR102430942B1 (ko) | 2022-08-08 |
DK3424924T3 (da) | 2023-08-28 |
US20190047964A1 (en) | 2019-02-14 |
BR112018016554A2 (pt) | 2018-12-26 |
HK1258545A1 (zh) | 2019-11-15 |
EP3424924A4 (en) | 2019-08-07 |
RU2741596C2 (ru) | 2021-01-27 |
EP3424924A1 (en) | 2019-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109071523B (zh) | 一种脲类化合物、其制备方法及其医药用途 | |
CN101679401B (zh) | 用于治疗肿瘤的作为met激酶抑制剂的2-氧代-3-苄基-苯并*唑-2-酮衍生物及相关化合物 | |
ES2630026T3 (es) | Derivados indazólicos sustituidos activos como inhibidores de cinasa | |
BR112018004175B1 (pt) | Composto pirazolo[3,4-d]pirimidina, composição farmacêutica, inibidor de her2 e agente antitumor contendo o dito composto e usos terapêuticos do dito composto | |
BR112018013218B1 (pt) | Derivado de acrilanilida, seus usos, e composição farmacêutica | |
BRPI0808888B1 (pt) | composto de fenil amino pirimidina para uso no tratamento de uma doença associada à quinase, processo para a preparação do composto, composição farmacêutica, e, implante | |
US20160244410A1 (en) | Pyridic ketone derivatives, method of preparing same, and pharmaceutical application thereof | |
EA019534B1 (ru) | ПРОИЗВОДНЫЕ 3-(3-ПИРИМИДИН-2-ИЛБЕНЗИЛ)-1,2,4-ТРИАЗОЛО[4,3-b]ПИРИДАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ Met КИНАЗЫ | |
WO2019154177A1 (zh) | 嘧啶类化合物、其制备方法及其医药用途 | |
CN108329258B (zh) | 含缩氨基脲结构的4-苯氧基吡啶类衍生物及其应用 | |
EP3176160A1 (en) | Pyridine-substituted 2-aminopyridine protein kinase inhibitors | |
CN114466840A (zh) | 乙酰辅酶a合成酶2(acss2)抑制剂及其使用方法 | |
WO2018137639A1 (zh) | 一种组蛋白甲基转移酶ezh2抑制剂、其制备方法及其医药用途 | |
CN107151233B (zh) | 含腙的嘧啶类衍生物及其用途 | |
CN110467616B (zh) | 含杂芳基取代哒嗪酮结构的三唑并吡嗪类化合物的制备及应用 | |
CN111247137A (zh) | 一种嘧啶类化合物、其制备方法及其医药用途 | |
CN114341128B (zh) | 双功能蛋白降解靶向嵌合体类化合物及其制备方法和医药用途 | |
TW202348235A (zh) | 吉西他濱抗癌衍生物及抗癌醫藥用途 | |
CN111484484B (zh) | 含芳杂环的2,4-二芳氨基嘧啶衍生物及其制备与应用 | |
CN110684022B (zh) | Set8赖氨酸甲基转移酶抑制剂及其中间体、制备方法和用途 | |
KR20220008313A (ko) | 퀴나졸리논계 화합물의 결정형 및 이의 제조방법 | |
BR112018016554B1 (pt) | Composto de uréia, método de preparação do mesmo, composição farmacêutica, uso do composto e uso da composição farmacêutica | |
WO2023046114A1 (zh) | 蝶啶酮衍生物及其应用 | |
WO2023168740A1 (zh) | 喹啉类化合物的新用途 | |
CN113354630B (zh) | 一种5,6-二氢苯并[h]喹唑啉类化合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1258545 Country of ref document: HK |
|
GR01 | Patent grant | ||
GR01 | Patent grant |